Vision Training for Age-Related Macular Degeneration
(FLAP Trial)
Trial Summary
What is the purpose of this trial?
A greater understanding of plasticity after central vision loss can inform new therapies for treating low vision and has the potential to benefit millions of individuals suffering from low vision. The treatment of low vision is particularly relevant to the mission of the NEI to support research on visual disorders, mechanisms of visual function, and preservation of sight. The comparison of different training and outcome factors is in line with the NIMH RDOC framework and studies in an aging population are consistent with the mission of the NIA.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment for Vision Training for Age-Related Macular Degeneration?
Is vision training for age-related macular degeneration safe?
How does the Vision Training treatment for Age-Related Macular Degeneration differ from other treatments?
The Vision Training treatment for Age-Related Macular Degeneration is unique because it focuses on improving visual skills through exercises like eye-movement training and biofeedback, rather than relying solely on magnification aids or medications. This approach aims to enhance reading speed, visual acuity, and quality of life by training the brain to use healthier parts of the retina more effectively.28101112
Eligibility Criteria
This trial is for adults aged 18-89 with severe vision impairment (20/100 or worse) due to Macular Degeneration, confirmed by an ophthalmologist. Participants must have had this condition for at least two years and live within 50 miles of the study site. Those with certain body measurements, metal implants, claustrophobia, hearing impairments, significant head injuries, mental health conditions like hallucinations/delusions, or specific tattoos near the head cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Training
Participants undergo perceptual learning training focusing on visual sensitivity, spatial integration, and attention and eye-movements.
Follow-up
Participants are monitored for changes in visual processing and brain plasticity after training completion.
Treatment Details
Interventions
- Combination training
- Training visual sensitivity
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
University of California, Riverside
Collaborator